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ABSTRACT 
Introduction: Expanding access to postpartum intrauterine contraception (PPIUC) can reduce 
unintended pregnancies and short inter-pregnancy intervals, however provision across Europe is 
limited. Our aim was to the determine the feasibility, clinical outcomes and patient satisfaction of 
providing immediate PPIUC after vaginal birth using a health services research model. Material 
and methods: Phased introduction of PPIUC across two Lothian maternity hospitals. All women 
intending vaginal birth during the study period without a contraindication to use of the method 
were eligible to receive PPIUC. Midwives and obstetric doctors were trained in vaginal PPIUC 
insertion using Kelly forceps. Women received information antenatally and had PPIUC insertion 
of either a levonorgestrel intrauterine system or copper intrauterine device  within 48 hours of 
vaginal birth. Follow-up was conducted in-person at six weeks’ postpartum and by telephone at 3, 
6 and 12 months. Primary outcomes were: uptake, complications (infection, uterine perforation), 
expulsion and patient satisfaction at 6 weeks; and method of continuation up to 12 months. 
Secondary outcomes included hazard ratio for expulsion adjusted for demographic and insertion-
related variables. Results: Uptake of PPIUC was 4.6% of all vaginal births. 465/447 (96.1%) of 
those requesting PPIUC successfully received it and most chose levonorgestrel intrauterine system 
(73%). At six weeks postpartum, the infection rate was 0.8%, there were no perforations and 
98.3% of women said they would recommend the service. The complete expulsion rate was 29.8% 
(n=113) and most had symptoms (n=79). Of the additional 121 devices removed, 118 were due to 
partial expulsion.  The rate of complete/partial expulsion was higher for insertions by midwives 
compared to doctors. The reinsertion rate after expulsion/removal was 87.6% and method 
continuation at 12 months was 79.6%. Conclusions: Routine PPIUC at vaginal birth is feasible. 
Complications were extremely rare. High expulsion rates may be observed in early stages of 
service introduction and with inexperienced providers. Reinsertion and therefore longer-term 
continuation rates of intrauterine contraception were very high. In settings with low rates of 
attendance for interval postpartum intrauterine contraception  insertion, PPIUC could be a useful 
intervention to prevent unintended and closely-spaced pregnancies.
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Postpartum contraception
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Abbreviations:
IUC intrauterine contraception 
PPIUC  postpartum intrauterine contraception
NHS National Health Service 
RCOG Royal College of Obstetricians and Gynaecologists
Key message
Vaginal PPIUC provision is feasible in a public maternity setting. Complications are low, but 
expulsion may be increased with inexperienced providers. High continuation suggests PPIUC is a 
useful intervention to reduce unintended pregnancies, especially where attendance for interval 
insertion is poor.
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INTRODUCTION
Unintended pregnancy in the postpartum period is common. One UK study found that at least one 
in 13 women attend for abortion within 12 months of childbirth1. For women who continue a 
pregnancy following a gap of less than 12 months between childbirth and subsequent conception - 
known as a short inter-pregnancy interval - there is an increased risk of preterm labour, fetal 
growth restriction and stillbirth2. Initiation of effective contraception has been shown to reduce the 
incidence of unintended pregnancy and short inter-pregnancy intervals, especially when started 
immediately postpartum3. As this is also a convenient and desirable option for women1, there is 
now an increasing requirement for maternity centres to offer a range of contraceptive services. 
Although both contraceptive and maternity care is provided free-of-charge in the UK under the 
National Health Service (NHS), there are still challenges in integrating these services, particularly 
for contraceptive methods requiring trained personnel to fit such as intrauterine contraception 
(IUC). 
NHS Lothian (Edinburgh and surrounding region) has two large maternity centres (two hospitals; 
approximately 9000 annual births) and has led numerous recent initiatives to improve access to 
postpartum contraception. This included the introduction of routine antenatal contraceptive 
counselling4 and the successful provision of IUC insertion at planned cesarean delivery5. 
However, most women have a vaginal birth and those intending to use IUC postpartum are 
required to attend their general practitioner or local sexual clinic several weeks after childbirth. 
Local data suggests that less than 50% of women attend for interval IUC insertion, even when 
provided with an appointment1.
Current clinical guidelines from UK, USA and World Health Organisation6–8 all support 
immediate postpartum intrauterine contraception (PPIUC) insertion. This can be performed in the 
10 minutes following placental delivery (post-placental insertion) and up to 48 hours after vaginal 
birth9. Whilst there is good evidence to support the safety of PPIUC 10,11, until recently much of 
the clinical experience originated from low-and-middle-income settings.
Although some high-income settings such as the US now offer PPIUC, it is not yet routinely 
available. The recommended technique for vaginal PPIUC insertion is one with which most A
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European maternity providers are unfamiliar. In a publicly-funded maternity setting such as the 
UK, the need to train large numbers of multi-disciplinary providers to ensure sufficient availability 
of fitters therefore presents challenges. 
Therefore, we sought to train maternity providers in vaginal PPIUC insertion in NHS Lothian and 
subsequently introduce and evaluate a routinely-available service, using a health services research 
model appraising both clinical and qualitative outcomes. Primary clinical outcomes of interest 
included uptake, complications (infection, perforation), expulsion and satisfaction at six-weeks’ 
postpartum, and method continuation up to 12 months.  Based on previous studies we anticipated a 
higher expulsion rate with vaginal PPIUC insertion10,11 and therefore our secondary aim was to 
determine the patient and insertion-related characteristics associated with expulsion. The 
acceptability and experience of women and healthcare staff were evaluated through a separately 
reported qualitative study. 
MATERIAL AND METHODS
The study was conducted across both NHS Lothian maternity services comprising St Johns’ 
Hospital (Hospital A; smaller regional centre) and Royal Infirmary of Edinburgh (Hospital B; 
large tertiary centre). The vaginal PPIUC service was intentionally introduced in a phased manner, 
firstly to Hospital A in January 2017 and 9 months later to Hospital B (October 2017). The 
recruitment period for both hospitals continued until June 2019. 
Any pregnant woman anticipating vaginal birth in the region, interested in using IUC for 
postpartum contraception and without a contraindication to the method (as per UK Medical 
Eligibility Criteria for Contraceptive Use9) was eligible to participate. Information about PPIUC 
and the study was provided by community midwives to all pregnant women during their 20-week 
antenatal visit, when contraception counselling routinely occurs in Lothian. Those who were 
eligible and wished to receive PPIUC completed a structured self-assessment form containing 
detailed information about the insertion procedure, risks and available methods; as well as consent 
to follow-up by clinical research staff. Women could choose to receive either a 52-mg 
levonorgestrel intrauterine system (LNG-IUS) (Mirena; Bayer plc, Reading, UK) or a five-year 
380mm2 copper intrauterine device  Cu-IUD)(UT380; Durbin, South Harrow, UK). PPIUC A
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intention and method choice was recorded in women’s electronic maternity record, and a 
designated sticky label applied to case-notes to assist in identifying them on admission to the birth 
unit.
Prior to service introduction, all obstetric doctors and a cohort of labour ward midwives were 
trained in vaginal PPIUC insertion using 33cm Kelly forceps (Roberts Surgical Healthcare Ltd, 
Kidderminster, UK). This technique has been widely described in the literature12 and is advocated 
by the Royal College of Obstetricians and Gynaecologists (RCOG)13. After delivery of the baby 
and placenta, ring forceps are applied to the anterior cervix to straighten the utero-cervical canal. 
The IUC device is removed from its pre-packaged inserter and advanced into the uterine cavity 
using Kelly forceps. After the forceps have reached the fundus (confirmed by external palpation 
with the non-dominant hand), the device is released from the forceps which are then removed, and 
threads trimmed flush with the cervix. 
Training workshops in vaginal PPIUC insertion were facilitated by clinical research staff (MC and 
colleagues) and consisted of education about risks and benefits of PPIUC, insertion training video 
(supplied by RCOG) and practical simulation using postpartum uterus models (Mama-U, 
Laerdal, Norway). One-to-one and small group workshops were conducted regularly throughout 
the study period. Following workshop attendance, inserters were required to maintain a logbook 
and perform a minimum of three competent procedures under supervision.  A ‘train-the-trainers’ 
model14 was used to increase the pool of available supervisors. Supervision was initially provided 
by the research team, who also delivered subsequent coaching for on-site trainers.  To become a 
‘trainer’, an individual was required to have sound knowledge of clinical and educational aspects 
of PPIUC, to have performed at least five ‘live’ insertions successfully and participated in at least 
one observed episode of supervision.  
Alongside training for in-hospital staff, educational sessions were provided for community 
healthcare staff, the main providers of antenatal care. All community midwifery ‘teams’ (ten in 
total, consisting 10 to 20 midwives covering designated geographical areas) were visited 
individually and given information about PPIUC and the study to enable them to counsel women 
about this option during routine antenatal contraceptive discussion4. Similar sessions were 
provided for local general practitioners and family nurses. This also included dissemination of A
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patient resources and visual aids to support PPIUC counselling. A full list of the resources 
developed to support training and implementation are detailed in a previous paper15. 
Women desiring PPIUC received routine antenatal and intrapartum care. After delivery, a trained 
PPIUC inserter (and supervisor) was contacted. A second eligibility assessment was performed by 
attending staff to identify any intrapartum contraindications to PPIUC insertion. Exclusion criteria 
included: 1) prolonged rupture of membranes (more than 36 hours); 2) clinical suspicion or 
treatment for chorioamnionitis; 3) postpartum hemorrhage (as defined by blood loss greater than 
1000ml). Insertion procedures were performed in the birth unit (or a designated area of the 
postnatal ward) within the first 48 hours after delivery depending on the availability of trained 
staff; concomitant clinical workload; and clinical needs and preference of the woman. This was 
felt to reflect a ‘normal’ clinical environment for maternity centres offering PPIUC. An ultrasound 
was not performed routinely after insertion. All insertion procedures were recorded in a designated 
PPIUC logbook and in the woman’s maternity record. Following insertion women were provided 
with written and verbal advice about possible signs of expulsion and infection, along with contact 
information for research staff. 
Details of insertion procedures (timing, location, staff member, analgesia), participant 
demographics and delivery information were obtained from maternity records. All women who 
received PPIUC were contacted within the first postpartum week and provided with a follow-up 
appointment at or around six weeks’ postpartum.  At the follow-up visit, women underwent pelvic 
examination to visualise and trim threads (if required) and a transvaginal ultrasound to confirm 
IUC location. They also completed a structured survey about relevant symptoms (pain, bleeding, 
thread issues), infant feeding status, resumption of sexual activity and their PPIUC experience 
(including main source of information, perceived coercion and if they would recommend PPIUC). 
Clinical outcomes recorded at this visit included complications (infection, uterine perforation), 
device expulsion and removal.
Complete expulsion was defined as a device that had been fully expelled from the uterine cavity 
prior to the initial follow-up (self-reported). Partial expulsion was defined as a device found to be 
located within the cervical canal (either wholly or in part) on clinical examination or ultrasound at 
initial follow-up and these were removed. Where no device was seen on ultrasound, an A
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abdominal/pelvic x-ray was performed to exclude uterine perforation. Infection was recorded if 
there was a self-reported or documented history of receiving antibiotics (and/or device removal) 
for suspected intrauterine/pelvic infection at or before the initial follow-up. Women were offered 
re-insertion of IUC following expulsion or removal. Where immediate re-insertion was not 
possible, for example due to recent unprotected sex, women were offered a further appointment 
and an alternative interim method. 
Further contact was made by research staff three, six and 12 months after the initial PPIUC 
insertion and a short telephone survey completed. Data collection included self-reported 
complications and continued IUC use. 
Statistical analyses
To determine PPIUC uptake under ‘normal conditions’, a convenience sample was chosen with no 
minimum sample size. The characteristics of the women who had IUC inserted and those who 
experienced an outcome of interest were described using counts and proportions (with 95% 
confidence intervals). We further reported those experiencing an expulsion by the characteristics 
of the women and insertion procedure, including the device type. Where the time to expulsion was 
unknown (in the absence of symptoms), times were treated as interval censored with the expulsion 
assumed to have occurred sometime between the date of insertion and initial follow-up. We fitted 
parametric survival models assuming the time to expulsion followed a Gompertz distribution, 
which allowed for the time to expulsion to be interval censored, right censored or known. The fit 
of the model was assessed by plotting the Cox-Snell residuals. As an individual clinician may 
perform multiple insertions, we allowed for this clustering by calculating robust standard errors. 
We also stratified the survival models by hospital to allow for possible differences in baseline 
hazards. Calculations were performed using Stata 15.1 (StataCorpl, College Station, TX, USA) 
Ethical approval
South-East Scotland Research Ethics Service provided written confirmation (December 2017) that 
the study met the criteria for ‘health services research’ and as such full NHS ethical review was 
not required. NHS Lothian quality improvement team approval was granted.A
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RESULTS
Uptake and insertion procedure
During the recruitment periods (Hospital A: 31st January 2017 to 31st May; Hospital B: 1st October 
2017 to 31st May 2019), 465 women requested PPIUC and were eligible at the time of delivery 
(Figure 1). This represented an uptake of 4.6% of all women who had a vaginal birth (assisted, 
unassisted or breech) in the region over the study periods (n=10119). Of these, 447 insertion 
procedures were successfully completed (96.1%) (Table 1). 
The mean age of participants was 30 years (range 16 to 44) and most (73%) opted for 
levonorgestrel intrauterine system insertion (73%). The mean delivery-to-insertion interval was 
6.6 hours (range 0 to 47); 28.2% (n=126) of insertions were performed within the first hour, 
increasing to 77.0% (n=342) within six hours. None were performed within 10 minutes of 
placental delivery. Sixty-three percent of insertions (n=240) were by midwives, and all except 13 
occurred in the labour ward. 
Eighteen women did not receive PPIUC (4.0%) for the following reasons: insertion abandoned 
due to technical difficulty (n=8) or patient discomfort (n=2), significant bleeding prior to insertion 
(n=6), woman changed her mind at insertion (n=1) and no staff available (n=1). 
Complications, expulsion and satisfaction 
Initial follow-up information was available for 379 women (84.8%) (Table 2). Three women 
(1.1%) were treated with antibiotics for suspected intrauterine infection (all within 10 days of 
delivery); two had their devices removed and further IUC inserted later. There were no cases of 
uterine perforation. Prior to the initial follow-up, 113 women (29.8%) spontaneously expelled 
their device. Of these expulsions, most were identified by the woman (n=79), while the remainder 
(n=34) were only confirmed following ultrasound and x-ray. At initial follow-up, 118 (31.0%) A
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women were found to have a partial expulsion.  Of these, 68 (57.6%) were diagnosed clinically 
with the device visibly extruding from cervix. All partially-expelled devices were removed. One 
other removal was performed at patient request. All removal procedures were performed easily 
within an outpatient clinic setting. Of the 231 women whose device was expelled or removed, 205 
(88.7%) chose to have another device inserted at (or shortly after) initial follow-up. 
In multivariate survival models, the rate of expulsion was associated with type of staff inserting 
and analgesia during delivery and previous IUC use (Table 3). Higher rates of expulsion were 
observed for insertions by midwives (versus doctors) and for non-regional anaesthesia (p<0.05). 
Parity did not appear to affect the expulsion rate. 
Of the 148 women with a correctly-sited device at initial follow-up, threads were visible in 120 
(81.1%) and 79 of these were trimmed (53.4%). Table 4 summarises information regarding 
satisfaction and PPIUC decision-making. Almost all women (98.3%) said they would recommend 
PPIUC. 
For women who did not attend initial follow-up (n=68), it was not possible to determine clinical 
outcomes and they were excluded from this analysis. If contact was made a later time-point, 
method continuation and pregnancy status were recorded (Figure 1). 
Continuation
Of the 265 potential participants who had reached the 12-month time-point, contact was made 
with 230 (86.8%) and 183 (79.6%) reported continued use of IUC. 
Among those who initially received PPIUC (n=379), eight pregnancies to date have been recorded 
within 12 months (2.1%). Six occurred in women who either did not attend initial follow-up (n=2) 
or declined re-insertion (or alternative method) following confirmed expulsion (n=4). One was a 
planned pregnancy after device removal at 10 months’ postpartum. Another pregnancy followed 
device removal for colposcopy at eight months’ postpartum. Pregnancy outcomes included: 
continuing pregnancy or live birth (n=5), early miscarriage (n=2) and surgically-managed ectopic 
pregnancy (n=1). A
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DISCUSSION
This study demonstrates that routine vaginal PPIUC is feasible to provide in a publicly-funded 
maternity setting. Almost 1 in 20 women having a vaginal birth chose PPIUC, comprising women 
of all ages and socioeconomic backgrounds, most of whom had not used IUC before. Most PPIUC 
insertions were successful despite relatively low rates of regional anaesthesia, and women were 
satisfied with their experience. Our separate qualitative paper reports further on the high 
acceptability of PPIUC in this cohort. 
This is one of the few studies from a high-income country to train both doctors and midwives in 
vaginal PPIUC insertion. Unlike previous studies which have focused predominantly on clinical 
outcomes of PPIUC within a trial setting using a small number of highly trained ‘inserters’, this 
study addresses the translation gap to demonstrate the feasibility and outcomes of providing 
PPIUC in a ‘real-world’ context. The study findings are supported by a robust follow-up pathway 
and low rate of participant loss. 
There was a very low incidence of insertion-related complications in line with existing 
evidence10,11. Infection/suspected infections were rare and there were no cases of perforation. The 
overall expulsion rate observed was higher than generally reported elsewhere, although rates in the 
literature do vary considerably (0-50%)10,11. Direct comparisons are also difficult due to variability 
in insertion techniques, follow-up and definitions of expulsion between studies. Recently 
published findings from a large-scale PPIUC initiative across six low and middle-income 
countries reported combined expulsion rates of under 4% 16 (similar to standard IUC insertion). 
This program involved training midwives, doctors and nurses using the same insertion technique 
as ours, with no apparent difference in expulsion between provider groups. 
In contrast, our analysis suggested a possible increase in the risk of partial and complete expulsion 
following midwife insertion compared to doctor. This more likely reflects the relative 
inexperience with IUC insertion in our midwife population and therefore a steeper learning curve. 
More generally, inserter experience has previously been linked to a reduction in expulsion rate17. 
We did not observe a reduction in the expulsion rate with increasing number of insertions, perhaps A
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due to the relatively small number of overall procedures performed by any individual. Our 
methodology involved a continuous accumulation of newly trained providers throughout the study 
period (80 in total) to ensure adequate provision. A higher number of providers ‘in-training’ 
combined with an overall lower uptake of PPIUC compared to low and middle-income country 
settings, meant less frequent insertion opportunities and a longer time-frame to achieve similar 
competency.  In this situation a higher minimum number of supervised insertions may be needed, 
particularly as ‘on-the-job’ mentoring has been noted to be integral to the success of PPIUC 
services12. 
The timing of insertion is another important factor in service provision. Immediate post-placental 
insertion (within 10 minutes of placental delivery) has been associated with a lower risk of 
expulsion in other studies compared to early postpartum insertion10. This could not be evaluated 
here as none of our insertion were truly ‘post-placental’ and only a small proportion (28%) were 
performed within the first hour. Again, this likely reflects some of the early challenges of service 
introduction, including timely access to a trained inserter and supervisor. While we did observe a 
reduction in the delivery-to-insertion interval as the study progressed, further improvement is 
needed as earlier post-partum insertion has logistical advantages such as preventing the need to 
return to the birth unit (from postnatal ward) for insertion and facilitating earlier hospital 
discharge. 
No other patient or insertion-related variables were found to be significant in relation to expulsion 
risk. Some studies have suggested a higher expulsion rate for intrauterine system  compared to 
copper intrauterine device18, although the overall evidence is conflicting. Most women in our 
study received an intrauterine system and we found little evidence of a difference in expulsion rate 
between the two devices, although further research from larger comparative trials is needed.
As mentioned previously, the major limitation to our approach was that both the introduction and 
evaluation of vaginal PPIUC provision were conducted concurrently. Thus, the early outcomes 
observed here may not fully reflect those once the service has become fully ‘embedded’, 
particularly in relation to the expulsion rate which should therefore be interpreted with some 
caution. Moreover, while these findings reflect the experience from a large UK maternity service, 
they may not be applicable to all settings. The use of routine ultrasound at follow-up may also A
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have led to higher removal rates due to the detection and removal of devices defined as ‘partially 
expelled’. Routine ultrasound is rarely included in PPIUC studies from low-income settings, and 
indeed the clinical significance of a non-fundally located IUC is unknown but can lead to removal 
which may in some instances be unnecessary19. Within routine service provision, access to 
ultrasound is likely to be more limited unless indicated on clinical grounds e.g. non-visible 
threads. While some studies have included the use of immediate post-insertion ultrasound, this has 
not been shown to reduce subsequent expulsion19 and could be a barrier to service provision. 
Several lessons can be learned from this translational study. It is important that women are fully 
informed about procedural risks (including expulsion), ideally during the antenatal period, and that 
providers continue to monitor outcomes to provide accurate estimates of risk. Whilst an important 
counselling point, most women in our study chose re-insertion of IUC following expulsion 
indicating an ongoing acceptability and motivation towards the method. However, it is 
acknowledged that IUC insertion is provided at no cost to women in our setting. Where 
contraception is not provided free-of-charge, the initial costs of PPIUC and possible re-insertion 
may limit the uptake and acceptability. The importance of a follow-up visit is strengthened given 
the observed pregnancies in those who did not attend, and the small number of women who did 
not recognise their device had expelled and could have been at-risk of pregnancy. We have 
modified our service in light of the high expulsion risk including individualised feedback for staff, 
provision of ‘refresher’ training and a more prolonged period of supervision. A dedicated 
postpartum IUC inserter has been developed which more closely resembles the standard non-
postpartum IUC inserters widely in use. In a recently conducted randomised-controlled trial by 
Blumenthal et al20, the dedicated postpartum inserter was favoured by healthcare professionals 
over forceps for ease of insertion. It is possible that such a device could overcome some of the 
challenges linked to training and insertion and may also lead to fewer expulsions. 
In public health terms, the high continuation rate following PPIUC is arguably the most important 
outcome. IUC use 3 months after PPIUC was 88.3%, which given that only 50% of women are 
expected to attend for interval insertion1,21 suggests that PPIUC addresses a key gap in provision. 
This high continuation rate was maintained at 12 months after PPIUC, with almost 4 out of 5 
women still using the method. Provided expulsion can be readily identified and early re-insertion 
facilitated if desired, PPIUC is a useful intervention to reduce unintended and closely-spaced A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
pregnancies. Although there is no current health economics data from the UK, a US study has 
reported the high cost-effectiveness of PPIUC, even up to expulsion rates exceeding those more 
widely reported in the literature22. Therefore, the benefits of PPIUC are likely to persist, 
particularly in settings with low attendance rates for interval IUC insertion. 
CONCLUSION
There is demand for PPIUC among women and despite the complexities associated with 
introducing this service, it is inherently achievable. To be successful, PPIUC programs require 
effective antenatal counselling, availability of appropriately-trained providers and a robust follow-
up pathway that includes access to ultrasound and the option for device re-insertion. New services 
may observe an initially high expulsion rate, particularly among those less familiar with IUC 
insertion. Shared learning from early-adopter sites can help to expand access to PPIUC. This may 
help to prevent unintended and closely-spaced pregnancies and reduce the unmet need for 
effective contraception in the postpartum period.
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Legends of Figure
Figure 1: Overall participant flow and device status including uptake and insertion, initial clinical 
review and continuation rates of  intrauterine contraception (3, 6 and 12 months). PPIUC, 
postpartum intrauterine contraception.
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Table 1: Characteristics of women enrolled who had device successfully inserted and who have initial 
review data available (n=379)
Characteristic Number of 
insertions 
(%)
Hospital A 171 (45)
B 208 (55)
Staff inserting Doctor 139 (37)
Midwife 240 (63)
Supervised No 245 (65)
Yes 134 (35)
Number of previous insertions carried out by clinician 0 78 (21)
1 56 (15)
2 42 (11)
3,4 or 5 92 (24)
6,7,8 or 9 65 (17)
10 or more 46 (12)
Age of woman 16 to 19 14 (4)
20 to 24 60 (16)
25 to 29 89 (23)
30 to 34 118 (31)
35 to 39 81 (21)
40 or older 17 (4)
SIMD 1 73 (19)
2 95 (25)
3 79 (21)
4 75 (20)
5 57 (15)
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Body Mass Index a < 18 (underweight) 5 (1)
18 to 24 (normal) 172 (46)
25 to 29 (overweight) 106 (28)
30 or more (obese) 93 (25)
Woman has previously used intrauterine 
contraception No 295 (78)
Yes 84 (22)
Number of previous births 0 108 (29)
1 149 (39)
2 or more 122 (32)
Mode of delivery OVD 41 (11)
SVD 338 (89)
Analgesia used during delivery Non-regional 320 (84)
Regional 59 (16)
Type of device inserted Copper 101 (27)
IUS 278 (73)
Number of hours after delivery when device was 
inserted 1 or less 106 (28)
>1 and ≤6 179 (47)
>6 and ≤12 33 (9)
>12 and ≤24 30 (8)
>24 and ≤48 31 (8)
Feeding mode reported at initial review Bottle 178 (47)
Breast 167 (44)
Mixed 34 (9)
a3 women with missing data. 
OVD, operative vaginal delivery; SVD, spontaneous vaginal delivery; IUS, intrauterine system;A
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Table 2: Summary of recorded complications and outcomes of postpartum intrauterine 
contraception insertion in those with initial follow-up data available (n=379).
Outcome/complication Number of cases (%) (95% confidence 
interval)
Uterine perforation
Infection (suspected and/or confirmed)
        + Device retained
        + Device removed
Complete device expulsion
        Identified before initial review (preceding symptoms)
        Identified at initial review (no preceding symptoms)
Removal of device
        Partial expulsion and/or placement concern
        Other reason
        
Re-insertion following expulsion/removal (n=234)
0 (0)
3 (0.8)
0
2 (0.5)
113 (29.8)
79 (20.8)
 34 (9.0)
121 (31.9)
118 (31.1)
3 (0.8)
 205 (87.6)
(0, 0.1)
(0.2, 2.3)
(0, 0.1)
(0.1, 1.9)
(25.3, 34.7)
(16.9, 25.3)
(6.3, 12.3)
(27.3, 36.9)
(26.5, 36.1)
(0.2, 2.3)
(82.7, 91.5)
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Table 3: Estimated hazard ratios for expulsion among women enrolled who had device 
successfully inserted and who have initial review data available (n=376a).
Partial or complete expulsion Complete expulsions only
Characteristic Adjusted hazard 
ratio (95% CI) P-value
Adjusted hazard ratio 
(95% CI) P-value
Staff inserting 0.045 0.056
Doctor 1 (reference) 1 (reference)
Midwife 1.46 (1.01, 2.12) 1.84 (0.99, 3.42)
Supervised 0.77 0.159
No 1 (reference) 1 (reference)
Yes 1.07 (0.7, 1.63) 1.64 (0.82, 3.25)
Number of previous insertions 
carried out by clinician 0.78 0.29
1 versus 0 1.05 (0.91, 1.22) 1.19 (0.91, 1.57)
2 versus 1 1.05 (0.91, 1.20) 1.18 (0.91, 1.52)
3 versus 2 1.04 (0.93, 1.16) 1.15 (0.93, 1.42)
4 versus 3 1.03 (0.95, 1.11) 1.11 (0.95, 1.30)
5 versus 4 1.01 (0.96, 1/07) 1.08 (0.97, 1.19)
7 versus 6 1.00 (0.97, 1.03) 1.03 (0.99, 1.07)
10 versus 9 0.99 (0.94, 1.03) 1.00 (0.94, 1.05)
Age of woman 0.093 0.82
25 versus 20 0.88 (0.66, 1.17) 1.04 (0.67, 1.60)
30 versus 20 0.86 (0.53, 1.40) 1.09 (0.53, 2.24)
35 versus 20 1.04 (0.60, 1.80) 1.19 (0.56, 2.55)
40 versus 20 1.39 (0.73, 2.65) 1.33 (0.54, 3.31)
Body Mass Index 0.50 0.31
25 versus 20 1.10 (087, 1.39) 1.21 (0.86, 1.68)
30 versus 25 1.07 (0.95, 1.21) 1.15 (0.96, 1.38)
Woman has previously used 
intrauterine contraception 0.28 0.034A
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No 1 (reference) 1 (reference)
Yes 0.82 (0.57, 1.18) 0.57 (0.34, 0.96)
Number of previous births 0.18 0.55
0 1 (reference) 1 (reference)
1 0.94 (0.65, 1.36) 1.18 (0.64, 2.16)
2 or more 0.68 (0.42, 1.1) 0.91 (0.48, 1.76)
Mode of delivery 0.50 0.62
OVD 1 (reference) 1 (reference)
SVD 1.21 (0.69, 2.12) 1.25 (0.52, 2.98)
Analgesia used during delivery 0.033 0.034
Non-regional 1 (reference) 1 (reference)
Regional 0.61 (0.38, 0.96) 0.43 (0.2, 0.94)
Type of device inserted 0.13 0.99
Copper 1 (reference) 1 (reference)
IUS 0.83 (0.64, 1.06) 1.00 (0.66, 1.52)
Number of hours after delivery 
when device was inserted 0.19 0.30
6 versus 1 0.93 (0.64, 1.34) 1.02 (0.61, 1.68)
12 versus 1 0.85 (0.49, 1.46) 0.96 (0.45, 2.05)
24 versus 1 0.70 (0.42, 1.18) 0.77 (0.38, 1.56)
48 versus 1 0.58 (0.32 1.05) 0.59 (0.28, 1.27)
Feeding mode reported at initial 
review 0.83 0.73
Bottle 1 (reference) 1 (reference)
Breast 0.94 (0.67, 1.31) 0.84 (0.5, 1.4)
Mixed 0.87 (0.53, 1.42) 1.05 (0.51, 2.18)
* a3 out of 379 women had BMI missing and were not included in the above analysis.
OVD, operative vaginal delivery; SVD, spontaneous vaginal delivery; IUS, intrauterine system;A
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Table 4: Outcomes for satisfaction and decision-making at initial follow-up after postpartum 
intrauterine contraception (PPIUC) insertion (n=346a).
Number (%)
Timing of decision for PPIUC
        Several weeks before delivery
        Within one week before delivery
        During labour
        Postnatal period (up to 48 hours)
        Not recorded
303 (87.6)
9 (2.6)
0 (0)
29 (8.4)
5 (1.4)
Main source of information about PPIUC
        Community midwife
        Antenatal clinic
        Labor ward staff
        Friend/family
        Poster/leaflet/website
        Other
        Not recorded
232 (67.0)
28 (8.1)
18 (5.2)
12 (3.5)
26 (7.5)
3 (0.9)
27 (7.8)
Felt pressure or coercion towards PPIUC
        No
        Yes
        Unsure
345 (99.7)
0
1 (0.3)
Would recommend PPIUC to friend/family
        No
        Yes
        Unsure
        
0
340
6
*a33 women with missing data at initial follow-up 
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Number of participants requesting PPIUC at 
vaginal birth (n=465) 
Number successful 
vaginal PPIUC insertions 
(n=447) 
No contact/initial review 
data available (n=68) 
Participants with initial 
review data available 
(n=379) 
(n =   ) 
Participants with device 
removed/expelled prior to 
initial review (n=115) 
 
Participants with device 
reinserted at initial review 
(n=205) 
Participants with device in 
situ at initial review 
(n=264) 
Participants with device 
removed at initial review 
(n=119) 
Participants with correctly 
sited device after initial 
review (n=350) 
 
Participants with device in 
situ at 3/12 (n=324; 88%) 
Data available (n=367) 
Participants with device in 
situ 6/12 (n=282; 84%) 
Data available (n=336) 
Participants with device 
in situ 12/12 (n=183; 80%) 
Data available (n=230) 
